Press Releases

 
Press Releases
  Date Title View
Mar 7, 2016
RADNOR, Pa., March 07, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS)...
Mar 1, 2016
RADNOR, Pa., March 01, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS)...
Jan 27, 2016
RADNOR, Pa., Jan. 27, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to t...
Dec 16, 2015
RADNOR, Pa., Dec. 16, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the developmen...
Dec 7, 2015
RADNOR, Pa., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to t...
Dec 3, 2015
RADNOR, Pa., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the developmen...
Nov 19, 2015
RADNOR, Pa., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the developmen...
Nov 12, 2015
RADNOR, Pa., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the developmen...
Nov 10, 2015
RADNOR, Pa., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the developmen...
Nov 6, 2015
RADNOR, Pa., Nov. 06, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) ("Marinus" or the "Company") announced the pricing of an underwritten public offering of 5,000,000 shares of common stock for a public offering price of $6.00 per share. The net proceeds to Marinus from this offering are expected to be approximately $2...
FirstPrevious
3
...
NextLast
= add release to Briefcase